Katherine Kalin Bach's most recent trade in SELLAS Life Sciences Group Inc was a trade of 63,400 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on Nov. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SELLAS Life Sciences Grp Inc | Katherine Bach Kalin | Director | Purchase of securities on an exchange or from another person at price $ 1.59 per share. | 19 Nov 2025 | 63,400 | 104,400 (2%) | 1% | 1.6 | 100,806 | Common Stock |
| SELLAS Life Sciences Grp Inc | Katherine Bach Kalin | Director | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 22 May 2025 | 20,000 | 41,000 (0%) | 0% | 1.8 | 36,000 | Common Stock |
| SELLAS Life Sciences Grp Inc | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Grp Inc | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 12,500 | 21,000 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Grp Inc | Bach Katherine Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Grp Inc | Katherine Kalin Bach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 6,000 | 8,500 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Grp Inc | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 9,500 | 9,500 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Grp Inc | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 2,500 | 2,500 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Grp Inc | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2022 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) |